![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HPSE2 |
Gene summary for HPSE2 |
![]() |
Gene information | Species | Human | Gene symbol | HPSE2 | Gene ID | 60495 |
Gene name | heparanase 2 (inactive) | |
Gene Alias | HPA2 | |
Cytomap | 10q24.2 | |
Gene Type | protein-coding | GO ID | GO:0006022 | UniProtAcc | Q8WWQ2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
60495 | HPSE2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.31e-02 | 8.55e-02 | 0.0155 |
60495 | HPSE2 | HTA11_2487_2000001011 | Human | Colorectum | SER | 9.98e-05 | 2.00e-01 | -0.1808 |
60495 | HPSE2 | HTA11_347_2000001011 | Human | Colorectum | AD | 2.38e-07 | 1.81e-01 | -0.1954 |
60495 | HPSE2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.09e-09 | 2.05e-01 | -0.059 |
60495 | HPSE2 | HTA11_10711_2000001011 | Human | Colorectum | AD | 6.53e-42 | 1.40e+00 | 0.0338 |
60495 | HPSE2 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.10e-02 | 1.70e-01 | 0.281 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05205 | Colorectum | AD | Proteoglycans in cancer | 70/2092 | 205/8465 | 1.37e-03 | 8.46e-03 | 5.39e-03 | 70 |
hsa052051 | Colorectum | AD | Proteoglycans in cancer | 70/2092 | 205/8465 | 1.37e-03 | 8.46e-03 | 5.39e-03 | 70 |
hsa052052 | Colorectum | SER | Proteoglycans in cancer | 58/1580 | 205/8465 | 4.37e-04 | 3.82e-03 | 2.77e-03 | 58 |
hsa052053 | Colorectum | SER | Proteoglycans in cancer | 58/1580 | 205/8465 | 4.37e-04 | 3.82e-03 | 2.77e-03 | 58 |
hsa052054 | Colorectum | MSS | Proteoglycans in cancer | 65/1875 | 205/8465 | 8.66e-04 | 5.38e-03 | 3.29e-03 | 65 |
hsa052055 | Colorectum | MSS | Proteoglycans in cancer | 65/1875 | 205/8465 | 8.66e-04 | 5.38e-03 | 3.29e-03 | 65 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HPSE2 | SNV | Missense_Mutation | c.767N>G | p.Ser256Cys | p.S256C | Q8WWQ2 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
HPSE2 | SNV | Missense_Mutation | novel | c.746N>A | p.Ala249Asp | p.A249D | Q8WWQ2 | protein_coding | tolerated(0.07) | probably_damaging(0.998) | TCGA-S3-AA15-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR |
HPSE2 | insertion | Nonsense_Mutation | novel | c.72_73insAAGAAAAGGTCTCAAACAACAAAGAGCTGAAAGGA | p.Gly25LysfsTer10 | p.G25Kfs*10 | Q8WWQ2 | protein_coding | TCGA-AN-A0AR-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
HPSE2 | insertion | Frame_Shift_Ins | novel | c.70_71insAGTTACAAAAG | p.Pro24GlnfsTer30 | p.P24Qfs*30 | Q8WWQ2 | protein_coding | TCGA-AN-A0AR-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
HPSE2 | SNV | Missense_Mutation | rs201787008 | c.1681C>T | p.Arg561Cys | p.R561C | Q8WWQ2 | protein_coding | deleterious(0) | possibly_damaging(0.548) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
HPSE2 | SNV | Missense_Mutation | novel | c.47N>G | p.Ser16Cys | p.S16C | Q8WWQ2 | protein_coding | deleterious_low_confidence(0.01) | benign(0.436) | TCGA-EA-A97N-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
HPSE2 | SNV | Missense_Mutation | c.174N>T | p.Lys58Asn | p.K58N | Q8WWQ2 | protein_coding | tolerated(0.1) | benign(0.146) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
HPSE2 | SNV | Missense_Mutation | rs778752620 | c.1349G>A | p.Arg450His | p.R450H | Q8WWQ2 | protein_coding | deleterious(0.04) | benign(0.007) | TCGA-UC-A7PF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
HPSE2 | SNV | Missense_Mutation | c.272N>A | p.Gly91Asp | p.G91D | Q8WWQ2 | protein_coding | tolerated(0.56) | probably_damaging(0.998) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
HPSE2 | SNV | Missense_Mutation | rs767720704 | c.1691N>A | p.Arg564Gln | p.R564Q | Q8WWQ2 | protein_coding | tolerated(0.1) | probably_damaging(0.968) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |